搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Chlamydia trachomatis DNA repair protein RadA homolog (radA) CSB-YP530707DSB
CSB-EP530707DSB
CSB-BP530707DSB
CSB-MP530707DSB
CSB-EP530707DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis V-type ATP synthase subunit I (atpI), partial CSB-YP530708DSB1
CSB-EP530708DSB1
CSB-BP530708DSB1
CSB-MP530708DSB1
CSB-EP530708DSB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized protein CT_309 (CT_309) CSB-YP530709DSB
CSB-EP530709DSB
CSB-BP530709DSB
CSB-MP530709DSB
CSB-EP530709DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 50S ribosomal protein L11 (rplK) CSB-YP530710DSB
CSB-EP530710DSB
CSB-BP530710DSB
CSB-MP530710DSB
CSB-EP530710DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Exodeoxyribonuclease 7 large subunit (xseA), partial CSB-YP530711DSB
CSB-EP530711DSB
CSB-BP530711DSB
CSB-MP530711DSB
CSB-EP530711DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Phosphoenolpyruvate-protein phosphotransferase (ptsI), partial CSB-YP530712DSB
CSB-EP530712DSB
CSB-BP530712DSB
CSB-MP530712DSB
CSB-EP530712DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Tyrosine recombinase XerC (xerC) CSB-YP530713DSB
CSB-EP530713DSB
CSB-BP530713DSB
CSB-MP530713DSB
CSB-EP530713DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized protein CT_355 (CT_355) CSB-YP530714DSB
CSB-EP530714DSB
CSB-BP530714DSB
CSB-MP530714DSB
CSB-EP530714DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) CSB-YP530715DSB
CSB-EP530715DSB
CSB-BP530715DSB
CSB-MP530715DSB
CSB-EP530715DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Porin AaxA (aaxA) CSB-YP530716DSB
CSB-EP530716DSB
CSB-BP530716DSB
CSB-MP530716DSB
CSB-EP530716DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis LL-diaminopimelate aminotransferase (dapL) CSB-YP530717DSB
CSB-EP530717DSB
CSB-BP530717DSB
CSB-MP530717DSB
CSB-EP530717DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Transcriptional repressor NrdR (nrdR) CSB-YP530718DSB
CSB-EP530718DSB
CSB-BP530718DSB
CSB-MP530718DSB
CSB-EP530718DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized periplasmic metal-binding protein CT_415 (CT_415) CSB-YP530719DSB
CSB-EP530719DSB
CSB-BP530719DSB
CSB-MP530719DSB
CSB-EP530719DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Uncharacterized protein CT_425 (CT_425) CSB-YP530720DSB
CSB-EP530720DSB
CSB-BP530720DSB
CSB-MP530720DSB
CSB-EP530720DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Sulfur-rich protein, serovar D (srp) CSB-YP530721DSB
CSB-EP530721DSB
CSB-BP530721DSB
CSB-MP530721DSB
CSB-EP530721DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Translocated actin-recruiting phosphoprotein (tarP) CSB-YP530722DSB
CSB-EP530722DSB
CSB-BP530722DSB
CSB-MP530722DSB
CSB-EP530722DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP530723DSB
CSB-EP530723DSB
CSB-BP530723DSB
CSB-MP530723DSB
CSB-EP530723DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 50S ribosomal protein L2 (rplB) CSB-YP530724DSB
CSB-EP530724DSB
CSB-BP530724DSB
CSB-MP530724DSB
CSB-EP530724DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis 50S ribosomal protein L3 (rplC) CSB-YP530725DSB
CSB-EP530725DSB
CSB-BP530725DSB
CSB-MP530725DSB
CSB-EP530725DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlamydia trachomatis (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP530726DSB
CSB-EP530726DSB
CSB-BP530726DSB
CSB-MP530726DSB
CSB-EP530726DSB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>